We’re committed to meaningfully integrating sustainability considerations into our business practices and culture.
Clinical research and development is complex. Finding the right partner shouldn’t be.
The work we do has a global impact, and we are committed to making it a positive one. Our corporate sustainability practice enables us to engage meaningfully with stakeholders, empower our team members, reduce our environmental impact, and evolve our business model through innovation.
Sustainable goals for a sustainable future.
We support the United Nations’ 17 Sustainable Development Goals, and our corporate goals align with three in particular:
- Health and Well-Being
- Gender Equality
- Industry Innovation and Infrastructure
We are also an IMPACT 2030 partner. IMPACT 2030 is a private sector, partnership-led initiative to achieve the UN’s goals. By working together, we believe we can make our world a healthier, more prosperous, and peaceful place.Read more about our partnership with IMPACT2030
Pain Studies at PRA Early Development Services
PRA Health Sciences offers a range of pain models to assess pain perception and the efficacy of experimental analgesics in healthy volunteers and…
First-in-Human Drug Evaluation at PRA Health Sciences & The Revised EMA Guideline on Early Clinical Trials
In July 2017, the European Medicines Agency (EMA) published its revised guidance on first-in-human (FIH) and early clinical trials. The revision…
Bioanalytical Laboratory - Assen the Netherlands
PRA’s state-of-the-art, GLP, compliant Bioanalytical Laboratory in Assen, the Netherlands, offers our clients industry-leading, high quality…